Alcon (ALC)
(Delayed Data from NYSE)
$78.77 USD
-0.07 (-0.09%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $78.79 +0.02 (0.03%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Alcon (ALC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$91.14 | $100.00 | $65.00 | 15.60% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for Alcon comes to $91.14. The forecasts range from a low of $65.00 to a high of $100.00. The average price target represents an increase of 15.6% from the last closing price of $78.84.
Analyst Price Targets (14)
Broker Rating
Alcon currently has an average brokerage recommendation (ABR) of 1.76 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 18 brokerage firms. The current ABR compares to an ABR of 1.72 a month ago based on 19 recommendations.
Of the 18 recommendations deriving the current ABR, 12 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 66.67% and 5.56% of all recommendations. A month ago, Strong Buy made up 68.42%, while Buy represented 5.26%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 12 | 13 | 13 | 13 | 11 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 3 | 2 | 3 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 1.76 | 1.72 | 1.72 | 1.65 | 1.81 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/4/2024 | Argus Research Corp. | John D Staszak | Strong Buy | Strong Buy |
3/1/2024 | Mizuho SecuritiesUSA | Anthony Petrone | Strong Buy | Strong Buy |
2/29/2024 | KeyBanc Capital Markets | Brett Fishbin | Strong Buy | Strong Buy |
2/28/2024 | Needham & Company | David Saxon | Moderate Buy | Moderate Buy |
1/30/2024 | Robert W. Baird & Co. | Jeffrey D Johnson | Strong Buy | Strong Buy |
1/7/2024 | BTIG | Ryan Zimmerman | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.76 |
ABR (Last week) | 1.72 |
# of Recs in ABR | 18 |
Average Target Price | $91.14 |
LT Growth Rate | 12.80% |
Industry | Medical - Instruments |
Industry Rank by ABR | 94 of 252 |
Current Quarter EPS Est: | 0.72 |